17. Salmennienmi U, Ruotsalainen E, Pihlajama¨ki J et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. [1] . 1a,25 (OH) 2 D 3 transcriptionally controls the expression of a particular set of target genes mediated through a nuclear vitamin D receptor (VDR) acting as a ligandinducible factor. Upon binding 1,25(OH) 2 D 3 , the VDR undergoes a conformational change and forms a complex with a retinoid X receptor (RXR). This VDR-RXR complex binds to DNA elements in the promoter regions of target genes described as vitamin D response elements (VDREs). Binding to these VDREs controls the rate of gene transcription. The rapid response presumably utilizes another signal transduction pathway that is probably linked to putative plasma membrane receptors for 1,25(OH) 2 D 3 , but its physiological role is not well understood.
Vitamin D-deficient knockout mice models
Targeted deletion of genes encoding 1a-OHase [2, 3] and of the nuclear VDR [4, 5] have provided useful mice models of inherited human diseases such as VDDR-I (also known as pseudovitamin D-deficiency rickets; PDDR) and VDDR-II. Mice in which the 1a-OHase gene was inactivated presented the same clinical phenotype as patients with PDDR, including undetectable levels of 1,25(OH) 2 D 3 , rickets and secondary hyperparathyroidism [2, 3] . On a normal diet, 1a-OHase knockout mice have an average life span of 12± 2 weeks [3, 6] . Previous studies indicated that daily injections of 1,25(OH) 2 D 3 completely rescued these 1a-OHase knockout mice [7] . Bone histology and histomorphometry confirmed that the rickets and osteomalacia were cured by this 1,25(OH) 2 D 3 supplementation. Blood biochemistry analysis revealed that the rescue treatment corrected the hypocalcaemia and secondary hyperparathyroidism. Interestingly, these 1a-OHase knockout mice were also rescued by a Ca enriched diet (2% w/w) [8] . Dietary Ca normalized the hypocalcaemia, secondary hyperparathyroidism and the biomechanical properties of the bone tissue. Comparable results were obtained in VDR knockout mice from which the bone phenotype could be completely rescued by feeding the animals an enriched Ca 2þ , phosphorus and lactose diet, suggesting that vitamin D deficiencies can be rescued by dietary Ca in a vitamin D-independent manner [4] . Other studies have however indicated that exogenous Ca may not entirely compensate for 1,25(OH) 2 D 3 deficiency in mice and piglets [9, 10] . In humans, beneficial effects of Ca infusions were reported in a child with hereditary resistance to 1,25(OH) 2 D 3 and alopecia [11] . Ca infusions may be an efficient alternative for the management of patients with this condition who are unresponsive to large doses of vitamin D derivatives. However, it is not completely clear whether dietary Ca is effective in humans, and studies are needed in which vitamin D-deficient subjects are treated with Ca enriched diets.
Gene products involved in high dietary Ca rescue of 1a-OHase knockout mice
The kidney has a predominant role in maintaining the Ca 2þ balance because it determines the final excretion of Ca 2þ in the urine. Active Ca 2þ reabsorption in the distal convoluted and connecting tubule comprises a sequence of processes involving apical Ca 2þ entry via transient receptor potential channel V5 (TRPV5), translocation of Ca 2þ through the cytosol by calbindins and extrusion over the basolateral membrane by the Na þ /Ca 2þ exchanger (NCX1) and plasma membrane Ca 2þ ATPase (PMCA1b) [12] (Figure 1) . Recently, it was demonstrated that the expression of these renal Ca 2þ transport proteins, with the exception of PMCA1b, is significantly downregulated in kidneys of 1a-OHase knockout mice, which is in line with a diminished Ca 2þ reabsorption capacity contributing to the development of the observed hypocalcaemia [6] . Intriguingly, high dietary Ca intake restored the decreased expression of the Ca 2þ transport proteins independently from 1,25(OH) 2 D 3 [6] . In order to identify gene products in the kidney that are regulated by high dietary Ca and/or 1,25(OH) 2 D 3 , cDNA microarray analysis (15 000 cDNAs) was performed on kidney samples from 1,25(OH) 2 D 3 -and high dietary Ca-treated 1a-OHase knockout mice. In this study, 1,25(OH) 2 D 3 induced a significant regulation of 1000 genes, whereas dietary Ca supplementation of the 1a-OHase knockout mice revealed 2000 controlled genes as indicated in the Venn diagram (Figure 2 ) [13] . Interestingly, 600 transcripts were regulated in both situations, suggesting the involvement in the dietary Ca-mediated rescue mechanism of these vitamin Ddeficient mice (Figure 2 ; for overview data sheets, please see: http://www.genomics.med.uu.nl/pub/bb/ kidney/). Conspicuous regulated genes encoded ion channels, channel-interacting proteins, kinases and other signalling molecules, and importantly Ca [14] . Second, other reports point to a role for the Ca 2þ -sensing receptor in the kidney that senses the ambient Ca 2þ concentration and transduces signals into the cell at the level of gene transcription (Figure 1) [15, 16] . Functional analysis should reveal the regulatory pathways of the Ca 2þ -sensitive proteins with respect to dietary Ca-mediated rescue of the disturbed Ca 2þ balance in vitamin D-deficient animals. The emerging tools of genomics and proteomics are enabling the in-depth study of relationships between diet, genetics and function. 
Is vitamin D indispensable?
Several studies supported the notion that vitamin D and Ca supplementation may prevent osteoporotic fractures in people known to be vitamin D deficient [17] . Osteoporosis, a systemic skeletal disease characterized by a low bone mass, is a major public health problem [18] . Nutritional deficiencies have a significant influence on the cause of osteoporosis. Previous studies indicated that a reduced supply of Ca 2þ is associated with decreased bone mass and osteoporosis, whereas a chronic and severe vitamin D deficiency leads to osteomalacia, a metabolic bone disease characterized by a decreased mineralization of bone [18] . Results of various clinical trials suggested that Ca 2þ supplementation may prevent vertebral fractures in the elderly. As outlined above, Ca supplementation in vitamin D-deficient mice models normalized the hypocalcaemia and restored the biomechanical properties of bone [3, 4, 8] . This treatment, however, does not appear as effective as 1,25(OH) 2 D 3 replacement therapy, since bone growth remained impaired [8] .
Hendy and co-workers demonstrated in 1a-OHase and/or VDR knockout mice that optimal dietary Ca absorption requires 1,25(OH) 2 D 3 /VDR, whereas skeletal mineralization was dependent on adequate ambient Ca 2þ and did not require the 1,25(OH) 2 D 3 / VDR system [19] . Together, these studies indicate that Ca 2þ cannot entirely substitute vitamin D in mineral and skeletal homeostasis, but the two agents have discrete and complementary functions.
In various clinical conditions associated with a disturbed Ca homeostasis, vitamin D analogues are administered. For instance, the treatment of choice for PDDR and for patients with chronic renal failure is long-term replacement therapy with 1,25(OH) 2 D 3 . Notably, the currently applied strategy of vitamin D and Ca 2þ supplementation to patients with chronic renal failure has been associated with adverse effects, such as vascular calcification and calciphylaxis. It would be interesting to compare the effectiveness of Ca supplementation with the treatment with vitamin D analogues in these patient groups. Based on present evidence, chelated Ca 2þ may be safely and effectively ingested by most people at doses generally recommended for treatment or prevention of Ca 2þ -related disorders [20] . Further studies on potential dietary Casensitive targets will provide insight into the molecular rescue mechanisms of dietary Ca supplementation.
